Definium Therape

CUSIP 24477V105COMMON STOCKDFTXQ4 2025

Definium Therape — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

11.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 17, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 17, 2026	Commodore Capital LP	13G/A	11.0%	7.43M	SEC
2	Feb 17, 2026	Driehaus Capital Management LLC	13G	6.6%	6.54M	SEC
3	Feb 17, 2026	Avoro Capital Advisors LLC	13G	5.1%	5.00M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Driehaus Capital Management LLC	6.54M	$87.53M
2	Marshall Wace, LLP	2.98M	$39.84M
3	Awm Investment Company, Inc.	1.39M	$18.62M
4	Ensign Peak Advisors, Inc	262.0K	$3.51M
5	Dark Forest Capital Management LP	30.7K	$410.6K
6	Sound Income Strategies, LLC	3.7K	$55.5K
7	Price T Rowe Associates Inc /Md/	52.2K	$700